Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business - Cybin (AMEX:CYBN), Small Pharma (OTC:DMTTF)
Small Pharma Inc. (OTCQB: DMTTF), the short-acting psychedelics biotech about to be purchased by Cybin Inc.
Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Small Pharma Inc. (OTCQB: DMTTF), the short-acting psychedelics biotech about to be purchased by Cybin Inc.
• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international...
Short-acting psychedelics biotech Small Pharma Inc.
Short-acting psychedelics biotech Small Pharma Inc. DMTTF has obtained a final order from the Supreme Court of British Columbia approving the announced plan…
Small Pharma Inc. ("Small Pharma"), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. (NEO:CYBN) ("Cybin"), a clinical-stage biopharmaceutical company committed to...